Two cases of diabetes mellitus type 1 after alemtuzumab treatment for multiple sclerosis: another probable secondary autoimmune disease

被引：9
|
作者：
Richter, Stephan [1 ]
Wagner, Bert [1 ]
Celius, Elisabeth Gulowsen [2 ,3 ]
机构：
[1] Neuro MVZ MIND Stuttgart, Charlottenstr 14, D-70182 Stuttgart, Germany
[2] Oslo Univ Hosp, Dept Neurol, N-0424 Oslo, Norway
[3] Univ Oslo, Inst Clin Med, Oslo, Norway
来源：
JOURNAL OF NEUROLOGY | 2019年 / 266卷 / 05期
关键词：
D O I：
10.1007/s00415-019-09257-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1270 / 1271
页数：2
相关论文
共 50 条
  • [1] Two cases of diabetes mellitus type 1 after alemtuzumab treatment for multiple sclerosis: another probable secondary autoimmune disease
    Stephan Richter
    Bert Wagner
    Elisabeth Gulowsen Celius
    Journal of Neurology, 2019, 266 : 1270 - 1271
  • [2] Acquired haemophilia A as a secondary autoimmune disease after alemtuzumab treatment in multiple sclerosis: A case report
    Pisa, M.
    Della Valle, P.
    Coluccia, A.
    Martinelli, V.
    Comi, G.
    D'Angelo, A.
    Moiola, L.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 : 403 - 405
  • [3] First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS
    Clas Malmeström
    Bengt A. Andersson
    Jan Lycke
    Journal of Neurology, 2014, 261 : 2016 - 2018
  • [4] First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS
    Malmestrom, Clas
    Andersson, Bengt A.
    Lycke, Jan
    JOURNAL OF NEUROLOGY, 2014, 261 (10) : 2016 - 2018
  • [5] Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
    Cossburn, M.
    Pace, A. A.
    Jones, J.
    Ali, R.
    Ingram, G.
    Baker, K.
    Hirst, C.
    Zajicek, J.
    Scolding, N.
    Boggild, M.
    Pickersgill, T.
    Ben-Shlomo, Y.
    Coles, A.
    Robertson, N. P.
    NEUROLOGY, 2011, 77 (06) : 573 - 579
  • [6] Recurrent autoimmune uveitis after alemtuzumab treatment for multiple sclerosis
    Portera, E.
    Ragonese, P.
    Di Liberto, D.
    Realmuto, S.
    Bianchi, A.
    Vazzoler, G.
    Dieli, F.
    Salemi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 941 - 942
  • [7] Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis
    Alamo, Angela
    Condorelli, Rosita A.
    La Vignera, Sandro
    Calogero, Aldo E.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2019, 33
  • [8] Can induction of autoimmune antibodies after alemtuzumab treatment of multiple sclerosis predict secondary autoimmunity?
    Sandgren, S.
    Novakova, L.
    Axelsson, M.
    Amirbeagi, F.
    Kockum, I.
    Olsson, T.
    Malmestrom, C.
    Lycke, J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 637 - 637
  • [9] Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease
    Alcala, Carmen
    Pzere-Miralles, F.
    Gasc, F.
    On Evole, M.
    Estutia, M.
    Gil-Perotin, S.
    Casanova, B.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 : 406 - 408
  • [10] Acquired hemophilia A and other autoimmune diseases after alemtuzumab therapy for multiple sclerosis: A report of two cases
    Comini-Frota, Elizabeth R.
    Freitas Campos, Angelo Pontes
    Gomes Neto, Antonio Pereira
    Christo, Paulo Pereira
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
12345